Wnt/β Catenin-Mediated Signaling Commonly Altered in Colorectal Cancer.

Area of Science:

• Oncology
• Molecular Biology
• Gastroenterology

Background:

• Colorectal cancer is a leading cause of cancer-related deaths worldwide.
• High incidence rates are observed in developed countries, with a 5% lifetime risk in the US.
• Understanding colorectal cancer mechanisms can impact oncology and other cancer treatments.

Purpose of the Study:

• To review the role of Wnt/β-catenin signaling in colorectal cancer.
• To highlight aberrant signaling as a characteristic feature of colorectal cancer.
• To identify potential therapeutic targets based on Wnt/β-catenin pathway.

Main Methods:

• Literature review of studies on Wnt/β-catenin signaling in colorectal cancer.
• Analysis of the mechanism of aberrant signaling in colorectal cancer initiation and progression.
• Synthesis of current knowledge on therapeutic strategies targeting Wnt/β-catenin.

Main Results:

• Aberrant Wnt/β-catenin signaling is a hallmark of colorectal cancer.
• This pathway plays a critical role in colorectal cancer cell proliferation, survival, and migration.
• Dysregulation of Wnt/β-catenin signaling contributes to tumor initiation and progression.

Conclusions:

• Targeting the Wnt/β-catenin pathway offers promising therapeutic strategies for colorectal cancer.
• Further research into this pathway may lead to novel treatments for colorectal cancer.
• Understanding Wnt/β-catenin signaling is crucial for advancing colorectal cancer therapy.